EUVIMEDEUVIMED entdecken
Open Access

CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells

Yongwei Zheng iD, Mei Yu, Yuhong Chen, Liquan Xue, Wen Zhu iD, Guoping Fu, Stephan W Morris, Renren Wen iD, Demin Wang

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Yongwei Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Versiti Blood Research Institute, Milwaukee, WI. Hauptthemen laut MEDLINE: NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The caspase recruitment domain family member (CARD)11-Bcl10-Malt1 signalosome controls TGF-β–activated kinase 1 (TAK1) activation and regulates BCR-induced NF-κB activation. In this study, we discovered that CARD19 interacted with TAK1 and inhibited TAB2-mediated TAK1 ubiquitination and activation. Although CARD19 deficiency in mice did not affect B cell development, it enhanced clonal deletion, receptor editing, and anergy of self-reactive B cells, and it reduced autoantibody production. Mechanistically, CARD19 deficiency increased BCR/TAK1-mediated NF-κB activation, leading to increased expression of transcription factors Egr2/3, as well as the E3 ubiquitin ligases c-Cbl/Cbl-b, which are known inducers of B cell tolerance in self-reactive B cells. RNA sequencing analysis revealed that although CARD19 deficiency did not affect the overall Ag-induced gene expression in naive B cells, it suppressed BCR signaling and increased hyporesponsiveness of self-reactive B cells. As a result, CARD19 deficiency prevented Bm12-induced experimental systemic lupus erythematosus. In summary, CARD19 negatively regulates BCR/TAK1-induced NF-κB activation and its deficiency increases Egr2/3 and c-Cbl/Cbl-b expression in self-reactive B cells, thereby enhancing B cell tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BSignal TransductionAnimalsMiceMAP Kinase Kinase KinasesUbiquitinationMAP Kinase Kinase Kinase 7

Substanzen

NF-kappa BMAP Kinase Kinase KinasesMAP Kinase Kinase Kinase 7

Autor:innen und Institutionen

  • Versiti Blood Research Institute, Milwaukee, WI.
  • HealthChart LLC, Memphis, TN.
  • Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI.

ORCID-Profile: Yongwei Zheng, Wen Zhu, Renren Wen

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • HHS | NIH | NHLBI | NHLBI Division of Intramural Research

Zitieren

APA

Zheng, Y., Yu, M., Chen, Y., Xue, L., Zhu, W., Fu, G., Morris, S. W., Wen, R., & Wang, D. (2023). CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200639

Vancouver

Zheng Y, Yu M, Chen Y, Xue L, Zhu W, Fu G, et al. CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200639

BibTeX
@article{Zheng2023,
  author = {Zheng, Yongwei and Yu, Mei and Chen, Yuhong and Xue, Liquan and Zhu, Wen and Fu, Guoping and Morris, Stephan W and Wen, Renren and Wang, Demin},
  title = {CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200639}
}
Kostenlos starten →